Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' DEFICIT, UNAUDITED

v3.24.1.1.u2
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' DEFICIT, UNAUDITED - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Dec. 31, 2022 $ 376,075 $ 119,075,925 $ (124,142,000) $ (4,690,000)
Beginning balance, shares at Dec. 31, 2022 376,074,096      
Common stock issued upon conversion of notes payable $ 7,480 136,520 144,000
Common stock issued upon conversion of notes payable, shares 7,480,000      
Warrants issued with convertible notes 47,000 47,000
Common stock issued upon exercise of warrants $ 983 38,017 39,000
Common stock issued upon exercise of warrants, shares 983,330      
Fair value of warrants issued as compensation 9,000 9,000
Net loss (334,000) (334,000)
Ending balance, value at Mar. 31, 2023 $ 384,538 119,306,462 (124,476,000) (4,785,000)
Ending balance, shares at Mar. 31, 2023 384,537,426      
Beginning balance, value at Dec. 31, 2023 $ 392,587 119,729,413 (125,366,000) (5,244,000)
Beginning balance, shares at Dec. 31, 2023 392,586,471      
Common stock issued upon conversion of notes payable $ 3,212 73,788 77,000
Common stock issued upon conversion of notes payable, shares 3,212,000      
Warrants issued with convertible notes 85,000 85,000
Common stock issued upon exercise of warrants $ 133 3,867 4,000
Common stock issued upon exercise of warrants, shares 133,332      
Fair value of warrants issued as compensation 5,000 5,000
Fair value of common stock issued for services $ 2,000 138,000 140,000
Fair value of common stock issued for services, shares 2,000,000      
Net loss (449,000) (449,000)
Ending balance, value at Mar. 31, 2024 $ 397,932 $ 120,035,068 $ (125,815,000) $ (5,382,000)
Ending balance, shares at Mar. 31, 2024 397,931,803